Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery

Sabine Schuster, Beáta Biri-Kovács, Bálint Szeder, Viktor Farkas, László Buday, Zsuzsanna Szabó, Gábor Halmos and Gábor Mező
Beilstein J. Org. Chem. 2018, 14, 756–771.

Supporting Information

Supporting Information File 1: Characterization data for compounds 1–6: RP-HPLC chromatograms and ESI–MS spectra; fragments of 1–6 produced by lysosomal rat liver homogenate; cellular uptake of K1, K2, 1, 2, 4, 5 by CLSM.
Format: PDF Size: 1.2 MB Download

Cite the Following Article

Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
Sabine Schuster, Beáta Biri-Kovács, Bálint Szeder, Viktor Farkas, László Buday, Zsuzsanna Szabó, Gábor Halmos and Gábor Mező
Beilstein J. Org. Chem. 2018, 14, 756–771.

How to Cite

Schuster, S.; Biri-Kovács, B.; Szeder, B.; Farkas, V.; Buday, L.; Szabó, Z.; Halmos, G.; Mező, G. Beilstein J. Org. Chem. 2018, 14, 756–771. doi:10.3762/bjoc.14.64

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Presentation Graphic

Picture with graphical abstract, title and authors for social media postings and presentations.
Format: PNG Size: 149.3 KB Download

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Srivastava, V.; Godara, P.; Jena, S. P.; Naik, B.; Singh, S.; Prajapati, V. K.; Prusty, D. Peptide-ligand conjugate based immunotherapeutic approach for targeted dismissal of non-structural protein 1 of dengue virus: A novel therapeutic solution for mild and severe dengue infections. International journal of biological macromolecules 2024, 260, 129562. doi:10.1016/j.ijbiomac.2024.129562
  • Fotie, J.; Matherne, C. M.; Mather, J. B.; Wroblewski, J. E.; Johnson, K.; Boudreaux, L. G.; Perez, A. A. The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds. International journal of molecular sciences 2023, 24, 16854. doi:10.3390/ijms242316854
  • Gomena, J.; Vári, B.; Oláh-Szabó, R.; Biri-Kovács, B.; Bősze, S.; Borbély, A.; Soós, Á.; Ranđelović, I.; Tóvári, J.; Mező, G. Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide-Drug Conjugates. International journal of molecular sciences 2023, 24, 3400. doi:10.3390/ijms24043400
  • Singh, H.; Singh, R.; Dan, A.; Vithalani, H.; Das, S. S.; Fernando, A. V.; Vankayala, R.; Bhatia, D.; Dhanka, M. Bioconjugated materials as potential vehicles for delivery of antibiotics/drugs. Bioconjugated Materials Part 2 Applications in Drug Delivery, Vaccine Formulations and Important Conjugates for Cancer Therapy; Elsevier, 2023; pp 29–58. doi:10.1016/bs.coac.2023.03.003
  • Godara, P.; Naik, B.; Meghwal, R.; Ojha, R.; Srivastava, V.; Prajapati, V. K.; Prusty, D. Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria. Life sciences 2022, 311, 121121. doi:10.1016/j.lfs.2022.121121
  • Agnihotri, T. G.; Jadhav, G. S.; Sahu, B.; Jain, A. Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders. Drug delivery and translational research 2022, 12, 3104–3120. doi:10.1007/s13346-022-01173-y
  • Schuster, S.; Juhász, É.; Halmos, G.; Neundorf, I.; Gennari, C.; Mező, G. Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates. International journal of molecular sciences 2022, 23, 5071. doi:10.3390/ijms23095071
  • Bharti, K.; Mishra, B. pH-Responsive Biomaterials in Drug Delivery. Functional Biomaterials; Springer Singapore, 2022; pp 37–74. doi:10.1007/978-981-16-7152-4_2
  • Xu, L.; Xu, S.; Xiang, T.; Liu, H.; Chen, L.; Jiang, B.; Yao, J.; Zhu, H.; Hu, R.; Chen, Z. Multifunctional building elements for the construction of peptide drug conjugates. Engineered Regeneration 2022, 3, 92–109. doi:10.1016/j.engreg.2022.02.004
  • Feni, L.; Neundorf, I. Different Approaches to Cyclize a Cell-Penetrating Peptide and to Tether Bioactive Payloads. Methods in molecular biology (Clifton, N.J.) 2021, 2371, 375–389. doi:10.1007/978-1-0716-1689-5_20
  • Alas, M.; Saghaeidehkordi, A.; Kaur, K. Peptide-Drug Conjugates with Different Linkers for Cancer Therapy. Journal of medicinal chemistry 2020, 64, 216–232. doi:10.1021/acs.jmedchem.0c01530
  • Vrettos, E. I.; Karampelas, T.; Sayyad, N.; Kougioumtzi, A.; Syed, N.; Crook, T.; Murphy, C.; Tamvakopoulos, C.; Tzakos, A. G. Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable "click" oxime bond tethers and preclinical evaluation against prostate cancer. European journal of medicinal chemistry 2020, 211, 113018. doi:10.1016/j.ejmech.2020.113018
  • Piorecka, K.; Smith, D. R. R.; Kurjata, J.; Stanczyk, M.; Stanczyk, W. A. Synthetic routes to nanoconjugates of anthracyclines. Bioorganic chemistry 2020, 96, 103617. doi:10.1016/j.bioorg.2020.103617
  • Tripodi, A. A. P.; Ranđelović, I.; Biri-Kovács, B.; Szeder, B.; Mező, G.; Tóvári, J. In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery. Pathology oncology research : POR 2019, 26, 1879–1892. doi:10.1007/s12253-019-00773-3
  • Ranđelović, I.; Schuster, S.; Kapuvári, B.; Fossati, G.; Steinkühler, C.; Mező, G.; Tóvári, J. Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice. International journal of molecular sciences 2019, 20, 4763. doi:10.3390/ijms20194763
  • Pavlíčková, V.; Jurášek, M.; Rimpelová, S.; Záruba, K.; Sedlák, D.; Simkova, M.; Kodr, D.; Staňková, E.; Fähnrich, J.; Rottnerová, Z.; Bartůněk, P.; Lapčík, O.; Drašar, P.; Ruml, T. Oxime-based 19-nortestosterone-pheophorbide a conjugate: bimodal controlled release concept for PDT. Journal of materials chemistry. B 2019, 7, 5465–5477. doi:10.1039/c9tb01301f
  • Lajkó, E.; Hegedüs, R.; Mező, G.; Kőhidai, L. Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells. International journal of molecular sciences 2019, 20, 4421. doi:10.3390/ijms20184421
  • Kiss, K.; Biri-Kovács, B.; Szabó, R.; Ranđelović, I.; Enyedi, K. N.; Schlosser, G.; Orosz, Á.; Kapuvári, B.; Tóvári, J.; Mező, G. Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems. European journal of medicinal chemistry 2019, 176, 105–116. doi:10.1016/j.ejmech.2019.05.016
  • Schuster, S.; Biri-Kovács, B.; Szeder, B.; Buday, L.; Gardi, J.; Szabó, Z.; Halmos, G.; Mező, G. Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification. Pharmaceutics 2018, 10, 223. doi:10.3390/pharmaceutics10040223
Other Beilstein-Institut Open Science Activities